| Location: | Maryland |
|---|---|
| Posted: | May 1, 2025 |
| Due: | May 14, 2025 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | CBER-2025-128782 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
MARKET RESEARCH PURPOSES ONLY
NOT A REQUEST FOR PROPOSAL OR SOLICITATION
The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requirement for a preventative maintenance, corrective/remedial maintenance repair service agreement on a 3730xL genetic analyzer (a capillary DNA sequencer) and accessories for data acquisition and analysis. DNA Analyzer assigned Serial Number: 33295-004.
The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required services. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort.
The associated North American Industry Classification System (NAICS) Code is- 811210 – Electronic and Precision Equipment Repair and Maintenance; the applicable Small Business Size Standard is $34 million.
Statement of Work
I. Statement of Need:
The 3730xL genetic analyzer is an instrument that performs capillary DNA sequencing. Scientists use genetic analyzers to determine sequences of DNA fragments of research interests such as: 1) confirming the authenticity of a DNA fragment amplified by polymerase chain reaction, (PCR); 2) verifying mutations introduced by mutagenesis; 3) validating the orientation of an inserted DNA fragment in an expression vector; 4) revealing sequences of isolated DNA fragments, etc. CBER scientists at FDA conduct research as well as perform regulatory functions. To meet the higher-volume sequencing demands of FDA scientists, FBR uses a high-capacity Applied Biosystems’ 3730xL sequencer and associated software programs for data acquisition and analysis. To maintain uninterrupted services to FDA scientists, this requisition is to purchase service contract for the 3730xL instrument and accessories. The equipment service contract expired on 3/10/2025.
II. Statement of Work:
Scientists at CBER are engaging in many aspects of biomedical research and conducting product reviewing relevant to drug and therapy efficacy and safety. DNA manipulations including PCR amplification of gene fragments, vector construction for gene expression, and mutagenesis of gene sequences are some of the routine tasks undertaken at CBER. These activities provide critical information for the identification of pathogenic strains involved in various diseases, or mutations that are responsible for phenotypes threatening the health and well-being of humans. Most DNA manipulations require sequence confirmation via DNA sequencing. Staff at FBR assists scientists in DNA sequencing using an Applied Biosystems’s 3730xL Genetic Analyzer. This instrument uses 48 or 96 capillaries that allow high throughput sequencing to meet increasing demands of CBER scientists’ needs for sequencing and data analysis. The requisition for a service contract ensures the instrument is maintained at optimal operation conditions for sequencing and data analysis which supports FDA scientists’ critical research and regulatory endeavors.
Performance requirements
-The contractor shall provide one (1) scheduled on-site planned preventive maintenance visit per year. The consumables required for PM visit shall be included in the contract. All costs for labor, travel, and parts required for preventative maintenance shall be included.
-The contractor shall provide unlimited on-site corrective maintenance and repairs within 2 business days of call for service where problems cannot be resolved remotely after 2 business days. All costs for labor, travel, and parts shall be included.
-The maintenance and repair activities shall be performed by the service engineers who are trained and certified, and the service provider should follow the Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM-certified replacement parts, components, subassemblies, etc.
-The contractor shall include unlimited software and firmware updates during the entire coverage period(s).
-The contractor shall include unlimited technical support (via phone and email) on software and hardware related issues and trouble-shooting capabilities, Monday through Friday (excluding Federal Holidays).
- Access by the FDA Technical Representative (TR) and system operator personnel to the manufacturer’s call center for technical assistance including software, which is staffed by senior engineers to provide a high level of expertise for troubleshooting the instrument.
-All maintenance and repair pricing must encompass costs for labor, travel, replacement parts, components, subassemblies, and any other necessary expenses related to the system.
- Deliverables: Service Records and Reports
The Contractor shall, commensurate with the completion of each service call or preventative maintenance visit, provide the end-user of the equipment and the Contracting Officer with a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced/repaired and detailing the reason for the service call, a detailed description of the work performed, the test instruments or other equipment used to affect the repair or otherwise perform the service, the name(s) and contact information of the technician who performed the repair/service, and for information purposes, the on-site hours expended and parts/components replaced.
Place of Performance
CBER
10903 New Hampshire Ave., Room 1106, Bldg. 52/72
Silver Spring, MD 20993.
Period of Performance
Base Period: July 1, 2025 through June 30, 2026
Option Year 1: July 1, 2026 through June 30, 2027
Option Year 2: July 1, 2027 through June 30, 2028
FOB Point Destination. All items shall include shipping and handling to the destination identified herein.
Alternative solutions will be considered insofar as any such alternate system and/or system components meet the minimum intended use of the system and brand name or equal technical requirements.
The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered products/services and components meet the technical requirements identified above. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product/service of a small business manufacturer or producer all interested parties may respond. At a minimum, responses shall include the following:
The government is not responsible for locating or securing any information, not identified in the response.
The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation.
Interested Parties shall respond with capability statements which are due by email to the point of contact listed below on or before May 14, 2025 by 13:00 hours (Central Time in Jefferson, Arkansas) to nick.sartain@fda.hhs.gov. Reference CBER-2025-128782.
Notice of Intent
Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small business, made available to full and open competition or procure through sole-source acquisition procedures.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

With GovernmentContracts, you can:
...Follow Intent to Sole Source: Statistical Analysis System (SAS) software licenses for DMCS ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 6/12/2026
.../2026 Publish Date: 5/6/2026 12:59:22 PM Main Category: Software maintenance and support Solicitation... ...
State Government of Maryland
Bid Due: 6/15/2026
...of the detector, data acquisition and data analysis software, and the line items ...
COMMERCE, DEPARTMENT OF
Bid Due: 6/12/2026
...AND TELECOM - BUSINESS APPLICATION/APPLICATION DEVELOPMENT SOFTWARE AS A SERVICE NAICS Code: 513210... ...
COMMERCE, DEPARTMENT OF
Bid Due: 6/11/2026